H.C. Wainwright analyst Ed Arce maintained a Buy rating on Albireo Pharma (ALBO – Research Report) today and set a price target of $80.00. The company's shares closed last Thursday at $23.55, close to its 52-week low of $22.59. According to TipRanks.com, Arce is a 5-star analyst with an average return of 16.2% and a 40.8% success rate. Arce covers the Healthcare sector, focusing on stocks such as Entasis Therapeutics Holdings, Madrigal Pharmaceuticals, and Paratek Pharmaceuticals. Currently, the analyst consensus on Albireo Pharma is a Strong Buy with an average price target of $76.00.
https://www.tipranks.com/news/blurbs/h-c-wainwright-thinks-albireo-pharmas-stock-is-going-to-recover-3?utm_source=advfn.com&utm_medium=referral
Albireo Pharma (NASDAQ:ALBO)
Historical Stock Chart
Von Dez 2021 bis Jan 2022 Click Here for more Albireo Pharma Charts.
Albireo Pharma (NASDAQ:ALBO)
Historical Stock Chart
Von Jan 2021 bis Jan 2022 Click Here for more Albireo Pharma Charts.